Smart Strategies to Overcome Tumor Hypoxia Toward the Enhancement of Cancer Therapy

Menghong Xu,Píng Wang,Shijie Sun,Liquan Gao,Lihong Sun,Lulu Zhang,Jinxia Zhang,Shumin Wang,Xiaolong Liang

DOI: https://doi.org/10.1039/d0nr05501h

IF: 6.7

2020-01-01

Nanoscale

Abstract:This review summarized intelligent strategies utilizing nanomaterials to overcome tumor hypoxia toward enhancing cancer treatment in emerging studies.

What problem does this paper attempt to address?

Strategies of Alleviating Tumor Hypoxia and Enhancing Tumor Therapeutic Effect by Macromolecular Nanomaterials

Zhenyu Jin,Qingyu Zhao,Shanmei Yuan,Wei Jiang,Yong Hu

DOI: https://doi.org/10.1002/mabi.202100092

2021-01-01

Macromolecular Bioscience

Abstract:AbstractHypoxia as one of the most prominent features in tumors, has presented negative effects on tumor therapies including photodynamic therapy, radiotherapy, and chemotherapies, leading to the tumor regeneration and metastasis. Recently, nanomedicines have been proposed to handle the hypoxia dilemma. Some nanomedicines alleviated hypoxia to enhance the therapeutic effect, others used hypoxia‐sensitive substances to treat tumor. Among them, macromolecular nanomaterials‐based nanomedicine has attracted increased research interest. However, the complicated tumor microenvironment disturbs the practical application of macromolecular nanomaterials to deal with hypoxia. This review highlights the influence of hypoxia on tumor therapy and some new strategies of using macromolecular nanomaterials to overcome hypoxia for effective tumor therapy.
Recent Advancements of Nanotechnology-Based Strategies for Overcoming Tumor Microenvironment Hypoxia

Jiangchao Wu,Jinyuan Song,Xianghong Yin,Jianghui Tang,Junlei Zhang,Xun Wang,Yongtao Ji,Yaxing Zhao,Dong Chen,Jianpeng Sheng,Xueli Bai,Tingbo Liang

DOI: https://doi.org/10.31083/j.fbl2705145

IF: 3.1

2022-01-01

Frontiers in Bioscience-Landmark

Abstract:Hypoxia is a typical characteristic of most solid malignancies, which has multiple effects on malignant phenotypes and biological behaviors of tumors including epithelial-mesenchymal-transition (EMT), invasion, migration, metastasis, autophagy, stem cell maintenance, pathological angiogenesis, drug resistance, and immunosuppression. Rcentlyumoand reversing the tumor hypoxic environment via nanotechnology has emerged as a novel therapeutic approach for the treatment of malignancies. The main strategies related to nanotechnology to alleviate or ameliorate hypoxic environment are as follows: (1) Bringing external oxygen to tumor hypoxic microenvironment; (2) Generating oxygen based on nanotechnology in situ; (3) Regulating the structure of the tumor microenvironment; (4) Decreasing oxygen consumption in the tumor microenvironment. In this review, we will discuss these nanotechnologies in detail.
Nanotechnological strategies to increase the oxygen content of the tumor

Junjie Zhang,Kaiyuan Tang,Runqi Fang,Jiaming Liu,Ming Liu,Jiayi Ma,Hui Wang,Meng Ding,Xiaoxiao Wang,Yanni Song,Dongliang Yang

DOI: https://doi.org/10.3389/fphar.2023.1140362

IF: 5.6

2023-03-09

Frontiers in Pharmacology

Abstract:Hypoxia is a negative prognostic indicator of solid tumors, which not only changes the survival state of tumors and increases their invasiveness but also remarkably reduces the sensitivity of tumors to treatments such as radiotherapy, chemotherapy and photodynamic therapy. Thus, developing therapeutic strategies to alleviate tumor hypoxia has recently been considered an extremely valuable target in oncology. In this review, nanotechnological strategies to elevate oxygen levels in tumor therapy in recent years are summarized, including (I) improving the hypoxic tumor microenvironment, (II) oxygen delivery to hypoxic tumors, and (III) oxygen generation in hypoxic tumors. Finally, the challenges and prospects of these nanotechnological strategies for alleviating tumor hypoxia are presented.

pharmacology & pharmacy
Extremely Effective Chemoradiotherapy by Inducing Immunogenic Cell Death and Radio-Triggered Drug Release under Hypoxia Alleviation

Chunqi Zhu,Xiaomen Guo,Lihua Luo,Zhe Wu,Zhenyu Luo,Mengshi Jiang,Junlei Zhang,Bing Qin,Yingying Shi,Yan Lou,Yunqing Qiu,Jian You

DOI: https://doi.org/10.1021/acsami.9b16837

IF: 9.5

2019-01-01

ACS Applied Materials & Interfaces

Abstract:Local hypoxia in solid malignancies often results in resistance to radiotherapy (RT) and chemotherapy (CT), which may be one of the main reasons for their failure in clinical application. Especially, oxygen is an essential element for enhancing DNA damage caused by ionizing radiation in radiotherapy. Here, two biomimetic oxygen delivery systems were designed by encapsulating hemoglobin (Hb) alone into a liposome (Hb-Lipo) or co-encapsulating Hb and doxorubicin (DOX) into a liposome (DOX-Hb-Lipo). Our data indicated that both Hb-Lipo and DOX-Hb-Lipo could effectively alleviate hypoxia in tumors. We demonstrated that RT plus tumor-targeting delivery of oxygen mediated by Hb-Lipo could significantly overcome the tolerance of hypoxic cancer cells to RT, showing significantly enhanced cancer-cell killing and tumor growth inhibition ability, mainly attributing to hypoxia alleviation and increased reactive oxygen species production under RT in cancer cells. Furthermore, a melanoma model that was quite insensitive to both RT and CT was used to test the efficacy of chemoradiotherapy combined with hypoxia alleviation. RT plus Hb-Lipo only caused a limited increase in antitumor activity. However, extremely strong tumor inhibition could be obtained by RT combined with DOX-Hb-Lipo-mediated CT, attributed to radio-triggered DOX release and enhanced immunogenic cell death induced by RT under an oxygen supplement. Our study provided a valuable reference for overcoming hypoxia-induced radioresistance and a useful therapeutic strategy for cancers that are extremely insensitive to chemo- or radiotherapy.
Nanoparticles-mediated Reoxygenation Strategy Relieves Tumor Hypoxia for Enhanced Cancer Therapy

Hong Wang,Jie Li,Yuqi Wang,Xiang Gong,Xiaoxuan Xu,Jiaoying Wang,Yaping Li,Xianyi Sha,Zhiwen Zhang

DOI: https://doi.org/10.1016/j.jconrel.2019.12.028

IF: 11.467

2020-01-01

Journal of Controlled Release

Abstract:Tumor hypoxia is a characteristic hallmark of malignant solid tumors, which remains an essential impediment to many current treatments like chemotherapy, radiotherapy, photodynamic therapy and immunotherapy, thereby leading to poor clinical prognosis after therapy. Rationally, modulating tumor hypoxia can be of great interest to augment the therapeutic efficacy of these treatments. In this review, we focus our discussion on current advances in nanoparticles-mediated tumor reoxygenation strategy for relieving tumor hypoxia to improve the therapeutic efficacy of versatile therapies. These nanoparticles can improve tumor oxygen levels via nanoparticles-mediated oxygen-carrying or oxygen-generating tactics to synergize the effectiveness of many current therapeutic modalities. Based on these considerable summaries and analyses, we propose some feasible perspectives on nanoparticles-based tumor reoxygenations to ameliorate the therapeutic outcomes.
Nanomedicine‐Enabled Modulation of Tumor Hypoxic Microenvironment for Enhanced Cancer Therapy

Jinping Wang,Beilu Zhang,Jingyu Sun,Yuhao Wang,Hongjun Wang

DOI: https://doi.org/10.1002/adtp.201900083

IF: 5.003

2019-09-30

Advanced Therapeutics

Abstract:Hypoxia is a common condition of solid tumors that is mainly caused by enhanced tumor proliferative activity and dysfunctional vasculature. In the treatment of hypoxic human solid tumors, many conventional therapeutic approaches (e.g., oxygen-dependent photodynamic therapy, anticancer drug-based chemotherapy or X-ray induced radiotherapy) become considerably less effective or ineffective. In recent years, various strategies have been explored to deliver or generate oxygen inside solid tumors to overcome tumorous hypoxia and show promising evidence to improve the antitumor efficiency. In this review, the extrinsic regulation of tumor hypoxia via nanomaterial delivery is discussed followed by a summary of the mechanisms through which the modulated tumor hypoxic microenvironment improves therapeutic efficacy. The review concludes with future perspectives, to specifically address the translation of nanomaterial-based therapeutic strategies for clinical applications.
Advances in nanomaterials for treatment of hypoxic tumor

Mei-Zhen Zou,Wen-Long Liu,Han-Shi Chen,Xue-Feng Bai,Fan Gao,Jing-Jie Ye,Han Cheng,Xian-Zheng Zhang

DOI: https://doi.org/10.1093/nsr/nwaa160

IF: 20.6

2020-07-08

National Science Review

Abstract:Abstract The hypoxic tumor microenvironment is characterized by disordered vasculature and rapid proliferation of tumors, resulting from tumor invasion, progression and metastasis. The hypoxic conditions restrict efficiency of tumor therapies, such as chemotherapy, radiotherapy, phototherapy and immunotherapy, leading to serious results of tumor recurrence and high mortality. Recently, research has concentrated on developing functional nanomaterials to treat hypoxic tumors. In this review, we categorize such nanomaterials into (i) nanomaterials that elevate oxygen levels in tumors for enhanced oxygen-dependent tumor therapy and (ii) nanomaterials with diminished oxygen dependence for hypoxic tumor therapy. To elevate oxygen levels in tumors, oxygen-carrying nanomaterials, oxygen-generating nanomaterials and oxygen-economizing nanomaterials can be used. To diminish oxygen dependence of nanomaterials for hypoxic tumor therapy, therapeutic gas-generating nanomaterials and radical-generating nanomaterials can be used. The biocompatibility and therapeutic efficacy of these nanomaterials are discussed.

multidisciplinary sciences
Nanomaterials for Tumor Hypoxia Relief to Improve the Efficacy of ROS-Generated Cancer Therapy

Changping Ruan,Kaihua Su,Dongmin Zhao,Ai Lu,Chaoran Zhong

DOI: https://doi.org/10.3389/fchem.2021.649158

IF: 5.5

2021-03-19

Frontiers in Chemistry

Abstract:Given the fact that excessive levels of reactive oxygen species (ROS) induce damage to proteins, lipids, and DNA, various ROS-generating agents and strategies have been explored to induce cell death and tumor destruction by generating ROS above toxic threshold. Unfortunately, hypoxia in tumor microenvironment (TME) not only promotes tumor metastasis but also enhances tumor resistance to the ROS-generated cancer therapies, thus leading to ineffective therapeutic outcomes. A variety of nanotechnology-based approaches that generate or release O 2 continuously to overcome hypoxia in TME have showed promising results to improve the efficacy of ROS-generated cancer therapy. In this minireview, we present an overview of current nanomaterial-based strategies for advanced cancer therapy by modulating the hypoxia in the TME and promoting ROS generation. Particular emphasis is put on the O 2 supply capability and mechanism of these nanoplatforms. Future challenges and opportunities of design consideration are also discussed. We believe that this review may provide some useful inspiration for the design and construction of other advanced nanomaterials with O 2 supply ability for overcoming the tumor hypoxia-associated resistance of ROS-mediated cancer therapy and thus promoting ROS-generated cancer therapeutics.

chemistry, multidisciplinary
Modulating Hypoxia via Nanomaterials Chemistry for Efficient Treatment of Solid Tumors

Yanyan Liu,Yaqin Jiang,Meng Zhang,Zhongmin Tang,Mingyuan He,Wenbo Bu

DOI: https://doi.org/10.1021/acs.accounts.8b00214

2018-10-16

Abstract:The common existence of hypoxia in solid tumors has been heavily researched because it renders tumors more resistant to most standard therapeutic methods, such as radiotherapy (RT), chemotherapy, and photodynamic therapy (PDT), and is associated with a more malignant phenotype and poor survival in patients with tumors. The development of hypoxia modulation methods for advanced therapeutic activity is therefore of great interest but remains a considerable challenge. Since the significant development of nanotechnology and nanomedicine, functionalized nanomaterials can be exploited as adjuvant "drugs" for these oxygen-dependent standard therapies or as hypoxia initiators for advanced new therapies to solid tumors. In this Account, we summarize our recent studies on the design and synthesis of nanomaterials with a set of desired chemistry benefits achievable by modulating hypoxia, suggesting a valid therapeutic option for tumors. The investigated strategies can be categorized into three groups: The first strategy is based on countering hypoxia. Considering that O2 deficiency is the major obstacle for the oxygen-dependent therapies, we initially developed methods to supply O2 by taking advantage of the hypoxia-responsive properties of nano-MnO2 or nanomaterials' photothermal effects for increased intratumoral blood flow. The second approach is to disregard hypoxia. Possible benefits of nanoagents include reducing/eliminating reliance on O2 or making O2 replacements as adjuvants to standard therapies. To this end, we investigated a nano-upconversion/scintillator with the capacity toup-/down-convert near-infrared light (NIR)/X-ray to luminescence in the ultraviolet/visible region fortype-I PDT with minimized oxygen-tension dependency or developed Fe-based nanomaterials for chemodynamic therapy (CDT) without external energy and oxygen participation for efficient free radical killing of deep tumors. The third strategy involves exploiting hypoxia. The unique biological characteristics of hypoxia are exploited to activate nanoagents for new therapies. To address the discrepancy between the nanoagents' demand and supply within the hypoxia region, a smart "molecule-nano" medicine that stays small-molecule-like in the bloodstream and turns into self-assembled nanovesicles after entry into the hypoxia region was constructed for hypoxia-adaptive photothermal therapy (PTT). In addition to traditional anti-angiogenesis therapy, we prepared Mg2Si nanoparticles by a special self-propagating high-temperature synthesis approach. These nanoparticles can directly remove the intratumoral oxygen via the oxidation reactions of Mg2Si and later efficiently block the rapid reoxygenation via tumor blood vessels by the resultant SiO2 microsheets for cancer starvation therapy. Taken together, these findings indicate that nanomaterials will assume a valuable role for anticancer exploration based on either their properties to make up oxygen deficiency or the use of hypoxia for therapeutic applications.
Research progress on tumor hypoxia-associative nanomedicine

Xiao-Xue Xu,Si-Yi Chen,Ning-Bo Yi,Xin Li,Si-Lin Chen,Zhixin Lei,Dong-Bing Cheng,Taolei Sun

DOI: https://doi.org/10.1016/j.jconrel.2022.09.003

IF: 11.467

2022-10-01

Journal of Controlled Release

Abstract:Hypoxia at the solid tumor site is generally related to the unrestricted proliferation and metabolism of cancerous cells, which can cause tumor metastasis and aggravate tumor progression. Besides, hypoxia plays a substantial role in tumor treatment, and it is one of the main reasons that malignant tumors are difficult to cure and have a poor prognosis. On account of the tumor specific hypoxic environment, many hypoxia-associative nanomedicine have been proposed for tumor treatment. Considering the enhanced targeting effect, designing hypoxia-associative nanomedicine can not only minimize the adverse effects of drugs on normal tissues, but also achieve targeted therapy at the lesion site. Mostly, there can be three strategies for the treatment of hypoxic tumor, including improvement of hypoxic environment, hypoxia responsive drug release and hypoxia activated prodrug. The review describes the design principle and applications of tumor hypoxia-associative nanomedicine in recent years, and also explores its development trends in solid tumor treatment. Moreover, this review presents the current limitations of tumor hypoxia-associative nanomedicine in chemotherapy, radiotherapy, photodynamic therapy, sonodynamic therapy and immunotherapy, which may provide a reference for clinic translation of tumor hypoxia-associative nanomedicine.

pharmacology & pharmacy,chemistry, multidisciplinary
Hypoxia-modulatory nanomaterials to relieve tumor hypoxic microenvironment and enhance immunotherapy: Where do we stand?

Cong-Shan Yuan,Zhen-Wei Deng,Di Qin,Yu-Zhi Mu,Xi-Guang Chen,Ya Liu

DOI: https://doi.org/10.1016/j.actbio.2021.02.030

IF: 10.633

2021-04-01

Acta Biomaterialia

Abstract:The past several years have witnessed the blooming of emerging immunotherapy, as well as their therapeutic potential in remodeling the immune system. Nevertheless, with the development of biological mechanisms in oncology, it has been demonstrated that hypoxic tumor microenvironment (TME) seriously impairs the therapeutic outcomes of immunotherapy. Hypoxia, caused by Warburg effect and insufficient oxygen delivery, has been considered as a primary construction element of TME and drawn tremendous attention in cancer therapy. Multiple hypoxia-modulatory theranostic agents have been facing many obstacles and challenges while offering initial therapeutic effect. Inspired by versatile nanomaterials, great efforts have been devoted to design hypoxia-based nanoplatforms to preserve drug activity, reduce systemic toxicity, provide adequate oxygenation, and eventually ameliorate hypoxic-tumor management. Besides these, recently, some curative and innovative hypoxia-related nanoplatforms have been applied in synergistic immunotherapy, especially in combination with immune checkpoint blockade (ICB), immunomodulatory therapeutics, cancer vaccine therapy and immunogenic cell death (ICD) effect. Herein, the paramount impact of hypoxia on tumor immune escape was initially described and discussed, followed by a comprehensive overview on the design tactics of multimodal nanoplatforms based on hypoxia-enabled theranostic agents. A variety of nanocarriers for relieving tumor hypoxic microenvironment were also summarized. On this basis, we presented the latest progress in the use of hypoxia-modulatory nanomaterials for synergistic immunotherapy and highlighted current challenges and plausible promises in this area in the near future.Statement of Significance: Cancer immunotherapy, emerging as a novel treatment to eradicate malignant tumors, has achieved a measure of success in clinical popularity and transition. However, over the last decades, hypoxia-induced tumor immune escape has attracted enormous attention in cancer treatment. Limitations of free targeting agents have paved the path for the development of multiple nanomaterials with the hope of boosting immunotherapy. In this review, the innovative design tactics and multifunctional nanocarriers for hypoxia alleviation are summarized, and the smart nanomaterial-assisted hypoxia-modulatory therapeutics for synergistic immunotherapy and versatile biomedical applications are especially highlighted. In addition, the challenges and prospects of clinical transformation are further discussed.

engineering, biomedical,materials science, biomaterials
Modulating hypoxia inducible factor-1 by nanomaterials for effective cancer therapy

Yun Sun,Zhiguo Zhou,Shiping Yang,Hong Yang

DOI: https://doi.org/10.1002/wnan.1766

2022-01-01

Abstract:Hypoxia, which is induced by abnormal tumor growth when it outstrips its oxygen supply, is a major character of cancer. The reaction of cells against hypoxia is mainly concentrated on the hypoxia-induced transcription factors (HIFs), especially HIF-1, which remain stabilized during hypoxia. Additionally, the oxygen-independent mechanism of regulating HIF-1 acts a vital part in different stages of tumor progression as well as chemo-/radio-/PDT resistance, resulting in poor curative effects and prognosis. In this review, we will outline the up-to-date information about how HIF-1 interferes with tumor metastasis and therapy resistance, followed by a detailed introduction of motivating techniques based on various nanomaterials to interfere with HIF signaling for effective cancer therapy. This article is categorized under: Nanotechnology Approaches to Biology > Nanoscale Systems in Biology Therapeutic Approaches and Drug Discovery > Emerging Technologies Therapeutic Approaches and Drug Discovery > Nanomedicine for Oncologic Disease
Recent Advances in Nanoplatform Construction Strategy for Alleviating Tumor Hypoxia

Jing Shen,Guobo Chen,Linghao Zhao,Guoyang Huang,Hui Liu,Baolin Liu,Yuqing Miao,Yuhao Li

DOI: https://doi.org/10.1002/adhm.202300089

IF: 10

2023-04-15

Advanced Healthcare Materials

Abstract:Hypoxia is a typical feature of most solid tumors and has important effects on tumor cells' proliferation, invasion, and metastasis. This is the key factor that leads to poor efficacy of different kinds of therapy including chemotherapy, radiotherapy, photodynamic therapy, etc. In recent years, the construction of hypoxia‐relieving functional nanoplatforms through nanotechnology has become a new strategy to reverse the current situation of tumor microenvironment hypoxia and improve the effectiveness of tumor treatment. Here, we focus on the main strategies and recent progress in constructing nanoplatforms to directly carry oxygen, generate oxygen in situ, inhibit mitochondrial respiration, and enhance blood perfusion to alleviate tumor hypoxia. We compared the advantages and disadvantages of these nanoplatforms. Meanwhile, nanoplatforms based on organic and inorganic substances were also summarized and classified. Through the comprehensive overview, we hope that the summary of these nanoplatforms for alleviating hypoxia could provide new enlightenment and prospects for the construction of nanomaterials in this field. This article is protected by copyright. All rights reserved

nanoscience & nanotechnology,engineering, biomedical,materials science, biomaterials
Nanomaterials to relieve tumor hypoxia for enhanced photodynamic therapy

Cheng Zhang,Wen-Jun Qin,Xue-Feng Bai,Xian-Zheng Zhang

DOI: https://doi.org/10.1016/j.nantod.2020.100960

IF: 17.4

2020-12-01

Nano Today

Abstract:<p>Photodynamic therapy (PDT) shows great potential for tumor treatment owing to its high spatiotemporal selectivity, minimal invasiveness and patient compliance. However, the therapeutic effect of PDT is seriously hindered by the tumor hypoxia in vivo. Hypoxia is a typical hallmark of the solid tumor microenvironment, which promotes the proliferation, invasion and metastasis of tumor cells. Additionally, the oxygen consumption during PDT will further aggravate the tumor hypoxia, resulting in multiple undesirable side-effects. To resolve these problems, many studies have been conducted to improve the efficacy of PDT by increasing oxygen concentration in tumor. Here, we focus on the current advances in nanomaterials-mediated tumor oxygenation via oxygen-carrying or oxygen-generating strategies to relieve tumor hypoxia. Based on the comprehensive overview, we hope these inspirations in hypoxia-associated anti-tumor therapy will provide perspectives in designing new oxygenation nanomaterials in this promising field.</p>

materials science, multidisciplinary,nanoscience & nanotechnology,chemistry
Nanomedicine-Based Strategies Assisting Photodynamic Therapy for Hypoxic Tumors: State-of-the-Art Approaches and Emerging Trends

Chun-Yan Shih,Pei-Ting Wang,Wu-Chou Su,Hsisheng Teng,Wei-Lun Huang

DOI: https://doi.org/10.3390/biomedicines9020137

IF: 4.757

2021-02-01

Biomedicines

Abstract:Since the first clinical cancer treatment in 1978, photodynamic therapy (PDT) technologies have been largely improved and approved for clinical usage in various cancers. Due to the oxygen-dependent nature, the application of PDT is still limited by hypoxia in tumor tissues. Thus, the development of effective strategies for manipulating hypoxia and improving the effectiveness of PDT is one of the most important area in PDT field. Recently, emerging nanotechnology has benefitted progress in many areas, including PDT. In this review, after briefly introducing the mechanisms of PDT and hypoxia, as well as basic knowledge about nanomedicines, we will discuss the state of the art of nanomedicine-based approaches for assisting PDT for treating hypoxic tumors, mainly based on oxygen replenishing strategies and the oxygen dependency diminishing strategies. Among these strategies, we will emphasize emerging trends about the use of nanoscale metal–organic framework (nMOF) materials and the combination of PDT with immunotherapy. We further discuss future perspectives and challenges associated with these trends in both the aspects of mechanism and clinical translation.

biochemistry & molecular biology,medicine, research & experimental,pharmacology & pharmacy
Oxygen-Based Nanocarriers to Modulate Tumor Hypoxia for Ameliorated Anti-Tumor Therapy: Fabrications, Properties, and Future Directions

Xianqiang Li,Yue Wu,Rui Zhang,Wei Bai,Tiantian Ye,Shujun Wang

DOI: https://doi.org/10.3389/fmolb.2021.683519

IF: 6.113

2021-07-01

Frontiers in Molecular Biosciences

Abstract:Over the past five years, oxygen-based nanocarriers (NCs) to boost anti-tumor therapy attracted tremendous attention from basic research and clinical practice. Indeed, tumor hypoxia, caused by elevated proliferative activity and dysfunctional vasculature, is directly responsible for the less effectiveness or ineffective of many conventional therapeutic modalities. Undeniably, oxygen-generating NCs and oxygen-carrying NCs can increase oxygen concentration in the hypoxic area of tumors and have also been shown to have the ability to decrease the expression of drug efflux pumps (e.g., P-gp); to increase uptake by tumor cells; to facilitate the generation of cytotoxic reactive oxide species (ROS); and to evoke systematic anti-tumor immune responses. However, there are still many challenges and limitations that need to be further improved. In this review, we first discussed the mechanisms of tumor hypoxia and how it severely restricts the therapeutic efficacy of clinical treatments. Then an up-to-date account of recent progress in the fabrications of oxygen-generating NCs and oxygen-carrying NCs are systematically introduced. The improved physicochemical and surface properties of hypoxia alleviating NCs for increasing the targeting ability to hypoxic cells are also elaborated with special attention to the latest nano-technologies. Finally, the future directions of these NCs, especially towards clinical translation, are proposed. Therefore, we expect to provide some valued enlightenments and proposals in engineering more effective oxygen-based NCs in this promising field in this comprehensive overview.

biochemistry & molecular biology
Anti-hypoxia nanosized drug delivery systems improving cancer therapy

Wenlu Yan,Tianqun Lang,Runqi Zhu,Xiao Zhu,Yu Li,Ting Wu,Qi Yin,Yaping Li

DOI: https://doi.org/10.1016/j.nantod.2022.101376

IF: 17.4

2022-02-01

Nano Today

Abstract:The abnormal tumor vascular system and long distances among cells inside tumors and blood vessels lead to restricted oxygen content and diffusion impairment in the tumor tissues, which are two essential factors contributing to hypoxia. Since hypoxia is an important feature of malignant solid tumors, it is closely related to the development of tumors and resistance to therapies. Recently, various anti-hypoxia treatments based on nanosized drug delivery systems (NDDSs) have been developed to enhance the efficacy of cancer therapy, providing a feasible solution for overcoming the obstacles to cancer treatments caused by hypoxia. In this review, the latest research progress on improving cancer therapy by anti-hypoxia NDDSs based on various mechanisms, including increasing oxygen supply, reducing oxygen consumption, and inhibiting hypoxia-related signaling pathways, is summarized. On the basis of discussing the advantages and shortcomings of these strategies, we propose possible directions and perspectives on further studies and clinical translation.

materials science, multidisciplinary,nanoscience & nanotechnology,chemistry
Recent progress of hypoxia-modulated multifunctional nanomedicines to enhance photodynamic therapy: opportunities, challenges, and future development

Yixin Sun,Dongyang Zhao,Gang Wang,Yang Wang,Linlin Cao,Jin Sun,Qikun Jiang,Zhonggui He

DOI: https://doi.org/10.1016/j.apsb.2020.01.004

IF: 14.903

2020-08-01

Acta Pharmaceutica Sinica B

Abstract:<p>Hypoxia, a salient feature of most solid tumors, confers invasiveness and resistance to the tumor cells. Oxygen-consumption photodynamic therapy (PDT) suffers from the undesirable impediment of local hypoxia in tumors. Moreover, PDT could further worsen hypoxia. Therefore, developing effective strategies for manipulating hypoxia and improving the effectiveness of PDT has been a focus on antitumor treatment. In this review, the mechanism and relationship of tumor hypoxia and PDT are discussed. Moreover, we highlight recent trends in the field of nanomedicines to modulate hypoxia for enhancing PDT, such as oxygen supply systems, down-regulation of oxygen consumption and hypoxia utilization. Finally, the opportunities and challenges are put forward to facilitate the development and clinical transformation of PDT.</p>

pharmacology & pharmacy
Application of nanotechnology for enhancing photodynamic therapy via ameliorating, neglecting, or exploiting tumor hypoxia

DanRong Hu,Meng Pan,Yan Yu,Ao Sun,Kun Shi,Ying Qu,ZhiYong Qian

DOI: https://doi.org/10.1002/viw2.6

2020-03-01

View

Abstract:Photodynamic therapy (PDT), an oxygen‐dependent modality, has been clinically approved and is considered a promising approach for cancer treatment. However, PDT shows noticeable limits due to the hypoxic nature of most solid tumor microenvironments. In recent years, various strategies have been developed to overcome tumor hypoxia either via oxygen‐replenishing approaches or via diminishing oxygen dependence. Both of these approaches have shown promise in reversing hypoxia‐relevant PDT resistance and thus improve antitumor efficacy. However, the low oxygen level at the tumor site is also an opportunity for the development of new therapeutic modalities, such as hypoxia‐activated chemotherapy, hypoxia‐inducible drug release, and starvation therapy. Therefore, a combination of these therapeutic modalities with PDT could promote their synergetic efficacy. Herein, we present an overview of the recent trend in the modulation and utilization of tumor hypoxia via nanomedicine‐based strategies, followed by a summary of the design and mechanisms of these nanosystems to improve PDT. Finally, current challenges and future perspectives for how PDT can achieve more extensive clinical applications for cancer therapy are discussed. A comprehensive review is presented on the recent progress of nanomedicine‐based strategies on intervening with tumor hypoxia for enhancing PDT efficacy. The strategies are based on three different starting point, ameliorating, neglecting, or exploiting tumor hypoxia, for a common purpose: improving PDT efficacy.

materials science, biomaterials,nanoscience & nanotechnology
Targeting Tumor Hypoxia with Nanoparticle-Based Therapies: Challenges, Opportunities, and Clinical Implications

Sujit Kumar Debnath,Monalisha Debnath,Arnab Ghosh,Rohit Srivastava,Abdelwahab Omri

DOI: https://doi.org/10.3390/ph17101389

IF: 4.6

2024-10-19

Pharmaceuticals

Abstract:Hypoxia is a crucial factor in tumor biology, affecting various solid tumors to different extents. Its influence spans both early and advanced stages of cancer, altering cellular functions and promoting resistance to therapy. Hypoxia reduces the effectiveness of radiotherapy, chemotherapy, and immunotherapy, making it a target for improving therapeutic outcomes. Despite extensive research, gaps persist, necessitating the exploration of new chemical and pharmacological interventions to modulate hypoxia-related pathways. This review discusses the complex pathways involved in hypoxia and the associated pharmacotherapies, highlighting the limitations of current treatments. It emphasizes the potential of nanoparticle-based platforms for delivering anti-hypoxic agents, particularly oxygen (O2), to the tumor microenvironment. Combining anti-hypoxic drugs with conventional cancer therapies shows promise in enhancing remission rates. The intricate relationship between hypoxia and tumor progression necessitates novel therapeutic strategies. Nanoparticle-based delivery systems can significantly improve cancer treatment efficacy by targeting hypoxia-associated pathways. The synergistic effects of combined therapies underscore the importance of multimodal approaches in overcoming hypoxia-mediated resistance. Continued research and innovation in this area hold great potential for advancing cancer therapy and improving patient outcomes.

pharmacology & pharmacy,chemistry, medicinal

Smart Strategies to Overcome Tumor Hypoxia Toward the Enhancement of Cancer Therapy

Strategies of Alleviating Tumor Hypoxia and Enhancing Tumor Therapeutic Effect by Macromolecular Nanomaterials

Recent Advancements of Nanotechnology-Based Strategies for Overcoming Tumor Microenvironment Hypoxia

Nanotechnological strategies to increase the oxygen content of the tumor

Extremely Effective Chemoradiotherapy by Inducing Immunogenic Cell Death and Radio-Triggered Drug Release under Hypoxia Alleviation

Nanoparticles-mediated Reoxygenation Strategy Relieves Tumor Hypoxia for Enhanced Cancer Therapy

Nanomedicine‐Enabled Modulation of Tumor Hypoxic Microenvironment for Enhanced Cancer Therapy

Advances in nanomaterials for treatment of hypoxic tumor

Nanomaterials for Tumor Hypoxia Relief to Improve the Efficacy of ROS-Generated Cancer Therapy

Modulating Hypoxia via Nanomaterials Chemistry for Efficient Treatment of Solid Tumors

Research progress on tumor hypoxia-associative nanomedicine

Hypoxia-modulatory nanomaterials to relieve tumor hypoxic microenvironment and enhance immunotherapy: Where do we stand?

Modulating hypoxia inducible factor-1 by nanomaterials for effective cancer therapy

Recent Advances in Nanoplatform Construction Strategy for Alleviating Tumor Hypoxia

Nanomaterials to relieve tumor hypoxia for enhanced photodynamic therapy

Nanomedicine-Based Strategies Assisting Photodynamic Therapy for Hypoxic Tumors: State-of-the-Art Approaches and Emerging Trends

Oxygen-Based Nanocarriers to Modulate Tumor Hypoxia for Ameliorated Anti-Tumor Therapy: Fabrications, Properties, and Future Directions

Anti-hypoxia nanosized drug delivery systems improving cancer therapy

Recent progress of hypoxia-modulated multifunctional nanomedicines to enhance photodynamic therapy: opportunities, challenges, and future development

Application of nanotechnology for enhancing photodynamic therapy via ameliorating, neglecting, or exploiting tumor hypoxia

Targeting Tumor Hypoxia with Nanoparticle-Based Therapies: Challenges, Opportunities, and Clinical Implications